Loading...
•
Mar 31, 2021
Akoya Q1 2021 Earnings Report
Akoya's first quarter performance demonstrated continued adoption of Codex and Phenoptics solutions, with strong financial results and progress across metrics.
Key Takeaways
Akoya Biosciences reported total revenue of $12.2 million for the first quarter of 2021, compared to $11.0 million in the first quarter of 2020. Product revenue was $10.0 million, with instrument revenue at $6.8 million and reagent revenue at $2.5 million.
Total revenue for the first quarter of 2021 was $12.2 million, compared to $11.0 million in the first quarter of 2020.
Product revenue was $10.0 million in the first quarter of 2021, compared to $8.9 million in the prior year period.
Instrument revenue was $6.8 million in the first quarter 2021, compared to $6.7 million in the first quarter 2020.
Reagent revenue was $2.5 million in the first quarter 2021, compared to $2.1 million in the first quarter 2020.
Revenue by Segment
Forward Guidance
Akoya expects full year 2021 revenue to be at least $52.0 million. The second quarter of 2021 is expected to have revenue growth of approximately 45% over the prior year quarter.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...